A retrospective analysis of mature T-and NK-cell lymphomas

二维码有效期 120s

摘要Mature T- and natural killer (NK)-cell lymphomas are het-erogeneous groups of malignant lymphoid neoplasms aris-ing from T and NK cells. The incidence of mature T- and NK-cell lymphomas is 2.1 per 100,000 people, according to a US report1. Due to the heterogeneity, rarity, and diagnostic complexity of these lymphomas, research focusing on treat-ment has been considerably hindered.

作者 Junlei Jia ^[1] Xiaohui Wang ^[1] Zheng Song ^[1] Shen Meng ^[2] Yue Fei ^[1] Jingwei Yu ^[1] Xia Liu ^[1] Xue Han ^[1] Lanfang Li ^[1] Lihua Qiu ^[1] Zhengzi Qian ^[1] Shiyong Zhou ^[1] Wenchen Gong ^[3] Bin Meng ^[3] Xiubao Ren ^[4] Xianhuo Wang ^[1] Huilai Zhang ^[1] 学术成果认领

作者单位 National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine,and Department of Lymphoma,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,The Sino-US Center for Lymphoma and Leukemia Research,Tianjin 300060,China ^[1] National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine,and Department of Lymphoma,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,The Sino-US Center for Lymphoma and Leukemia Research,Tianjin 300060,China;Department of Radiation Oncology,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250117,China ^[2] Department of Pathology,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin 300060,China ^[3] Department of Immunology/Biotherapy,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin 300060,China ^[4]

栏目名称 LETTER

DOI 10.20892/j.issn.2095-3941.2023.0464

发布时间 2024-04-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交